Tower Cold Chain, a pharmaceutical container specialist, has unveiled the KTEvolution 12, a pyramid-shaped container for regulating internal temperature, setting a new standard in small parcel solutions for pharmaceutical products.
Unveiled at LogiPharma 2024, the KTEvolution 12 integrates Tower’s existing phase-change materials (PCM) or dry ice into a novel configuration. This patent-pending plate system guarantees improved internal temperature consistency even when the container is placed on its side – a first in the cold chain sector.
Purpose-built for last-mile delivery, laboratory distribution and clinical trials, The KTEvolution 12 provides the safe transport of thermally sensitive products requiring internal temperatures ranging from -60°C to above +20°C with maximum product protection.
Tailored specifically for the transportation needs of life science products, the container provides security throughout the pharmaceutical supply chain.
With an internal payload up to 12 L, Tower’s latest product maintains thermal control for over 96 hours without the use of external power or human intervention during transit, meaning products can be reliably shipped both domestically and internationally in a parcel-sized box.
“The KTEvolution 12’s design not only ensures superior temperature consistency but also prioritises durability and sustainability,” said Martin Hawes, Global Head of Product Development at Tower Cold Chain. “The solutions sees a 30% increase in thermal performance compared to semi-reusable solutions.”
This design not only guarantees weatherproofing and washability but also minimises the risk of microbial and bacterial contamination of products, aligning with circular economy principles.
As well as its easy care credentials, the container is designed for ease of handling due to its compatibility with real-time data logging softwares and GPS live tracking.
